Literature DB >> 17133963

[Maternal and fetal morbidity in obese pregnant women].

Gustavo Romero Gutiérrez1, Francisco Javier Urbina Ortiz, Ana Lilia Ponce Ponce de León, Norma Amador.   

Abstract

OBJECTIVE: To determine the maternal and fetal morbidity in obese pregnant women compared with non-obese pregnant women. PATIENTS AND METHODS: It was carried out a case-control study. There were included 342 patients who had a body mass index previous to the pregnancy of 18.5 to 24.9 (control group) and 342 pregnant women with body mass index > 30 (group of obese women). We registered the mother and newborns' data to evaluate their morbidity. The groups were compared with Student's t test or Mann Whitney's U test for continuous data and chi-square or Fisher exact test for categorical variables.
RESULTS: We found more macrosomic newborns in the group of obese women (p = 0.003) and a higher number of caesarean sections (48.8 vs 37.4%, p = 0.003). The maternal morbidity characterized by gestational diabetes was higher in the obese ones (3.5 vs 0.58%, p = 0.015). Other variables as preterm delivery, stillbirths, malformations, admissions to the neonatal intensive care unit, as well as the development of hypertensive disorders of pregnancy were not significant.
CONCLUSION: We found higher maternal and fetal morbidity in obese women. Therefore, these patients should be considered as carriers of high-risk pregnancies. This strategy could avoid complications associated to this group of patients.

Entities:  

Mesh:

Year:  2006        PMID: 17133963

Source DB:  PubMed          Journal:  Ginecol Obstet Mex        ISSN: 0300-9041


  2 in total

1.  The Neglected Problem of Obesity during Pregnancy in Mexico: Secondary Data Analysis of the 2018 National Survey of Health and Nutrition.

Authors:  Svetlana V Doubova; Eduardo Ortiz-Panozo; Ricardo Pérez-Cuevas
Journal:  Matern Child Health J       Date:  2022-10-06

2.  Maternal obesity and occurrence of fetal macrosomia: a systematic review and meta-analysis.

Authors:  Laura Gaudet; Zachary M Ferraro; Shi Wu Wen; Mark Walker
Journal:  Biomed Res Int       Date:  2014-12-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.